Volume 222, Issue Supplement_5
1 October 2020
Cover image
Cover image
Alana Mermin-Bunnell, watercolor on paper, 2020
ISSN 0022-1899
EISSN 1537-6613
Issue navigation
Volume 222, Issue Supplement_5, 1 October 2020
Infectious Diseases and Injection Drug Use: Public Health Burden and Response
SUPPLEMENT ARTICLES
INTRODUCTION
Infectious Diseases and Injection Drug Use: Public Health Burden and Response
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S213–S217, https://doi.org/10.1093/infdis/jiaa432
Use of Population-Based Surveys for Estimating the Population Size of Persons Who Inject Drugs in the United States
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S218–S229, https://doi.org/10.1093/infdis/jiaa318
Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S230–S238, https://doi.org/10.1093/infdis/jiz673
HIV AND HCV
Responding to Outbreaks of Human Immunodeficiency Virus Among Persons Who Inject Drugs—United States, 2016–2019: Perspectives on Recent Experience and Lessons Learned
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S239–S249, https://doi.org/10.1093/infdis/jiaa112
Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S250–S258, https://doi.org/10.1093/infdis/jiaa128
Human Immunodeficiency Virus (HIV) Outbreak Investigation Among Persons Who Inject Drugs in Massachusetts Enhanced by HIV Sequence Data
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S259–S267, https://doi.org/10.1093/infdis/jiaa053
Human Immunodeficiency Virus Testing, Diagnosis, Linkage to Care, and Prevention Services Among Persons Who Inject Drugs, United States, 2012–2017
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S268–S277, https://doi.org/10.1093/infdis/jiaa143
Human Immunodeficiency Virus Prevention for People Who Use Drugs: Overview of Reviews and the ICOS of PICOS
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S278–S300, https://doi.org/10.1093/infdis/jiaa008
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S301–S311, https://doi.org/10.1093/infdis/jiaa130
Assessing County-Level Vulnerability for Opioid Overdose and Rapid Spread of Human Immunodeficiency Virus and Hepatitis C Infection in South Dakota
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S312–S321, https://doi.org/10.1093/infdis/jiaa231
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S322–S334, https://doi.org/10.1093/infdis/jiz659
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S335–S345, https://doi.org/10.1093/infdis/jiz686
Human Immunodeficiency Virus Testing Among People Who Inject Drugs in Rural West Virginia
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S346–S353, https://doi.org/10.1093/infdis/jiz598
Development of an Interdisciplinary Telehealth Model of Provider Training and Comprehensive Care for Hepatitis C and Opioid Use Disorder in a High-Burden Region
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S354–S364, https://doi.org/10.1093/infdis/jiaa141
Hepatitis C Among High-Risk Alabamians: Disease Burden and Screening Effectiveness
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S365–S375, https://doi.org/10.1093/infdis/jiaa207
Rapid Versus Laboratory-Based Testing for HIV and Hepatitis C at a Drug Detoxification Treatment Center: A Randomized Trial
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S376–S383, https://doi.org/10.1093/infdis/jiaa162
Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S384–S391, https://doi.org/10.1093/infdis/jiz694
Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S392–S400, https://doi.org/10.1093/infdis/jiaa142
Serious Mental Illness Among Young People Who Inject Drugs: An Assessment of Injection Risks and Healthcare Use
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S401–S409, https://doi.org/10.1093/infdis/jiaa238
From Hospital to the Community: Redesigning the Human Immunodeficiency Virus (HIV) Clinical Service Model to Respond to an Outbreak of HIV Among People Who Inject Drugs
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S410–S419, https://doi.org/10.1093/infdis/jiaa336
Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S420–S428, https://doi.org/10.1093/infdis/jiaa337
INVASIVE BACTERIAL AND FUNGAL INFECTIONS
National Public Health Burden Estimates of Endocarditis and Skin and Soft-Tissue Infections Related to Injection Drug Use: A Review
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S429–S436, https://doi.org/10.1093/infdis/jiaa149
Tracking Substance Use Complications: A Collaborative Analysis of Public Health and Academic Medical Center Records on Drug Use-Associated Infective Endocarditis
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S437–S441, https://doi.org/10.1093/infdis/jiaa160
Injection Drug Use-Associated Candidemia: Incidence, Clinical Features, and Outcomes, East Tennessee, 2014–2018
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S442–S450, https://doi.org/10.1093/infdis/jiaa024
Trends in Morbidity, Mortality, and Cost of Hospitalizations Associated With Infectious Disease Sequelae of the Opioid Epidemic
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S451–S457, https://doi.org/10.1093/infdis/jiaa012
Not Just Endocarditis: Hospitalizations for Selected Invasive Infections Among Persons With Opioid and Stimulant Use Diagnoses—North Carolina, 2010–2018
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S458–S464, https://doi.org/10.1093/infdis/jiaa129
SYPHILIS AND OTHER SEXUALLY TRANSMITTED DISEASES
The Emerging Intersection Between Injection Drug Use and Early Syphilis in Nonurban Areas of Missouri, 2012–2018
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S465–S470, https://doi.org/10.1093/infdis/jiaa056
Methamphetamine Injection Among Young Men Who Have Sex With Men: Risk for Human Immunodeficiency Virus Transmission in a Los Angeles Cohort
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S471–S476, https://doi.org/10.1093/infdis/jiz610
INTEGRATED TREATMENT OF INFECTIONS AND SUBSTANCE USE DISORDERS
The Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program’s Response to the Opioid Epidemic
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S477–S485, https://doi.org/10.1093/infdis/jiaa230
Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S486–S493, https://doi.org/10.1093/infdis/jiaa001
Feasibility and Safety of Outpatient Parenteral Antimicrobial Therapy in Conjunction With Addiction Treatment for People Who Inject Drugs
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S494–S498, https://doi.org/10.1093/infdis/jiaa025
An Integrated Hospital Protocol for Persons With Injection-Related Infections May Increase Medications for Opioid Use Disorder Use but Challenges Remain
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S499–S505, https://doi.org/10.1093/infdis/jiaa005
Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S506–S512, https://doi.org/10.1093/infdis/jiaa055
A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections
The Journal of Infectious Diseases, Volume 222, Issue Supplement_5, 1 October 2020, Pages S513–S520, https://doi.org/10.1093/infdis/jiz516
